Michael A Dyer Selected Research

Michael A Dyer Research Topics

Disease

46	Neoplasms (Cancer) 04/2024 - 10/2005
29	Retinoblastoma (Glioblastoma, Retinal) 01/2021 - 07/2004
15	Neuroblastoma 04/2024 - 01/2011
5	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 04/2014
5	Carcinogenesis 03/2017 - 07/2007
4	Retinal Degeneration 10/2016 - 12/2004
3	Laryngeal Neoplasms (Laryngeal Cancer) 09/2020 - 10/2019
3	Schizophrenia (Dementia Praecox) 01/2013 - 02/2008
2	Esophageal Neoplasms (Esophageal Cancer) 10/2023 - 01/2023
2	Cognitive Dysfunction 10/2022 - 02/2008
2	Leukemia 11/2021 - 01/2011
2	Rhabdomyosarcoma 01/2017 - 01/2011
2	Melanoma (Melanoma, Malignant) 01/2015 - 06/2014
2	Ganglion Cysts (Ganglion) 06/2009 - 05/2006
2	Blindness (Hysterical Blindness) 04/2009 - 12/2004
2	Infections 01/2009 - 06/2002
1	Microphthalmos 10/2023
1	Inflammation (Inflammations) 10/2023
1	Eye Diseases (Eye Disease) 01/2023
1	Amyloidosis 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Adenocarcinoma 07/2022
1	Cardiotoxicity 11/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021
1	Anus Neoplasms (Anal Cancer) 03/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Cytopenia 01/2020
1	ATR-X syndrome 11/2019
1	Squamous Cell Carcinoma of Head and Neck 10/2019
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2019
1	X-Linked Mental Retardation (Mental Retardation, X Linked) 03/2017
1	Thalassemia 03/2017
1	Disease Susceptibility (Diathesis) 10/2016
1	Genomic Instability 01/2016

Drug/Important Bio-Agent (IBA)

21	Retinaldehyde (Retinal)IBA 10/2023 - 07/2004
10	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2003
7	RNA (Ribonucleic Acid)IBA 04/2024 - 03/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2012
5	ChromatinIBA 11/2019 - 01/2014
3	Adrenergic Agents (Adrenergic Drugs)IBA 04/2024 - 10/2022
3	CytokinesIBA 01/2022 - 01/2020
3	Histones (Histone)IBA 03/2017 - 01/2012
3	NucleotidesIBA 04/2014 - 06/2013
3	nutlin 3IBA 06/2011 - 11/2007
3	Topotecan (Hycamtin)FDA LinkGeneric 06/2011 - 10/2005
2	ProteomeIBA 10/2022 - 10/2018
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2020
2	Interleukin-2 (IL2)IBA 12/2019 - 04/2018
2	MTOR InhibitorsIBA 01/2019 - 07/2015
2	Drug CombinationsIBA 01/2019 - 10/2005
2	Retroelements (Retrotransposon)IBA 03/2017 - 01/2016
2	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 10/2005
2	Syk KinaseIBA 01/2016 - 11/2014
2	Nicotine FDA Link 01/2013 - 02/2008
2	MicroRNAs (MicroRNA)IBA 09/2012 - 01/2012
2	Carboplatin (JM8)FDA LinkGeneric 01/2011 - 10/2005
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2008 - 02/2008
1	metariboadenosine triphosphorousIBA 01/2023
1	Small Nuclear Ribonucleoproteins (snRNP)IBA 10/2022
1	U1 Small Nuclear RibonucleoproteinIBA 10/2022
1	Amyloid (Amyloid Fibrils)IBA 10/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	AntigensIBA 01/2022
1	CX 5461IBA 11/2021
1	Topoisomerase I InhibitorsIBA 11/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2021
1	Small Nuclear RNA (snRNA)IBA 01/2020
1	Small Cytoplasmic RNAIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 12/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2019
1	Interleukin-15 (Interleukin 15)IBA 12/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019
1	AntibodiesIBA 04/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2018
1	KIR ReceptorsIBA 04/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2018
1	HeterochromatinIBA 03/2017
1	adavosertibIBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	Ribosomal DNA (rDNA)IBA 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016

Therapy/Procedure

23	Therapeutics 01/2023 - 07/2004
13	Drug Therapy (Chemotherapy) 04/2024 - 10/2005
6	Immunotherapy 10/2022 - 06/2013
4	Radiotherapy 01/2023 - 06/2014
3	Aftercare (After-Treatment) 01/2022 - 01/2013
2	Chemoradiotherapy 03/2021 - 10/2019
2	Intravitreal Injections 11/2014 - 01/2009
1	Neoadjuvant Therapy 10/2023
1	Brachytherapy 01/2023
1	Catheters 07/2022
1	Laryngectomy 10/2019
1	Precision Medicine 10/2016